Recurrent vulvar cancer refers to cancer that has returned after initial treatment, presenting unique challenges for both patients and healthcare teams in choosing the most appropriate therapeutic approach.
Understanding Recurrent Vulvar Cancer
When vulvar cancer comes back after treatment, doctors call this recurrent vulvar cancer. This means that cancer cells have begun growing again after a period when the disease appeared to be successfully treated. Recurrence happens in approximately 24% of cases after primary treatment, whether that treatment involved surgery alone or surgery combined with radiation therapy[1]. The cancer can return in the same area where it first appeared, called a local recurrence, or it may appear in other parts of the body.
The location where the cancer returns plays an important role in determining what treatment options are available. When cancer comes back only in the pelvis area, doctors may use different approaches than if the cancer has spread to lymph nodes or distant organs. Previous treatments also matter significantly, especially whether radiation therapy was used during the first round of treatment[3]. Each person’s situation is unique, which is why healthcare teams carefully evaluate multiple factors before recommending a treatment plan.
Causes of Recurrence
Recurrent vulvar cancer happens when cancer cells that survived the initial treatment begin growing again. These cells may have been too small to detect with available imaging or tests at the end of treatment, or they may have been resistant to the therapies used. Even when surgery appears to have removed all visible cancer, microscopic cancer cells can sometimes remain in the surrounding tissues or travel through the lymphatic system or bloodstream to other parts of the body.
The original characteristics of the cancer play a role in recurrence risk. Cancers that had spread to lymph nodes during the initial diagnosis are more likely to return. The depth of the original tumor’s invasion into surrounding tissues also affects the chance of recurrence. Cancers that were more advanced at the time of first diagnosis generally carry a higher risk of coming back, even after successful initial treatment.
Risk Factors for Recurrence
Several factors can increase the likelihood that vulvar cancer will return after treatment. The stage of the original cancer is one of the most important factors. Women whose cancer had spread beyond the vulva at initial diagnosis face a higher risk of recurrence. The presence of cancer cells in the lymph nodes at the time of first treatment is particularly significant, as this indicates the cancer had already begun spreading through the body’s lymphatic system.
The type and extent of initial treatment also influence recurrence risk. Women who could not receive complete surgical removal of the tumor due to its location or other health concerns may face higher recurrence rates. Similarly, if the surgical margins were close, meaning cancer cells were found near the edge of the removed tissue, the risk of local recurrence increases. The specific type of vulvar cancer matters as well, with some varieties being more aggressive and more likely to return than others.
Signs and Symptoms
Recognizing the signs of recurrent vulvar cancer is crucial for early detection and treatment. Women who have been treated for vulvar cancer should remain vigilant about changes in the vulval area. A new lump or mass in the vulva or groin area can signal recurrence. These lumps might feel firm or hard to the touch, and they may or may not cause discomfort initially.
Changes in the appearance of the vulvar skin should prompt immediate medical attention. This includes areas that look different from the surrounding skin, whether darker, lighter, redder, or showing other color changes. Thickened or rough patches of skin that weren’t present before can also indicate returning cancer. Some women notice wart-like growths or ulcers that don’t heal within a reasonable time frame.
Pain or discomfort in the vulvar area represents another potential warning sign. This pain might occur during daily activities, during urination, or during sexual activity. Persistent itching or burning sensations that don’t improve with typical treatments may also signal recurrence. Unexplained bleeding from the vulvar area, especially if it’s not related to menstruation in women who are still menstruating, requires immediate evaluation.
Swelling in the groin area can indicate that cancer has spread to the lymph nodes. This swelling might appear as visible lumps or a general fullness in one or both sides of the groin. Any of these symptoms warrant prompt consultation with a healthcare provider, even though many of these signs can also be caused by benign conditions unrelated to cancer recurrence.
Diagnosis and Detection
After completing treatment for vulvar cancer, regular follow-up appointments become essential for detecting any recurrence early. During these visits, healthcare providers perform thorough physical examinations of the vulvar area, checking for any visible changes or abnormalities. They also examine the groin area to check for swollen lymph nodes that might indicate cancer spread.
If something suspicious is found during a physical examination, doctors use various tests to determine whether cancer has returned. A biopsy, which involves removing a small sample of tissue for laboratory examination, remains the most definitive way to diagnose recurrent vulvar cancer. The tissue sample is examined under a microscope by a specialist who looks for cancer cells and determines their characteristics.
Imaging tests help doctors understand the extent of recurrence. Computed tomography (CT) scans use X-rays to create detailed cross-sectional images of the body, helping identify tumors in the pelvis, abdomen, or chest. Magnetic resonance imaging (MRI) uses magnetic fields and radio waves to produce detailed images, particularly useful for examining soft tissues in the pelvic area. Positron emission tomography (PET) scans can detect cancer cells throughout the body by identifying areas with increased metabolic activity.
Treatment Approaches
Treatment for recurrent vulvar cancer typically involves a combination of several approaches, tailored to each woman’s specific situation. The treatment plan depends on where the cancer has returned, how far it has spread, whether lymph nodes contain cancer cells, and what treatments were used initially[3]. Surgery remains one of the main treatment options when the recurrence is localized and surgically accessible.
Surgical Options
Surgery for recurrent vulvar cancer ranges from relatively minor procedures to major operations, depending on the extent of recurrence. For small, localized recurrences, doctors may perform a wide excision to remove the cancerous area along with a margin of healthy tissue around it. This approach aims to ensure all cancer cells are removed while preserving as much normal tissue as possible.
When cancer has returned more extensively, a complete radical vulvectomy may be necessary. This operation removes the entire vulva, including the clitoris, along with deeper tissues under the vulvar skin and nearby lymph nodes[3]. While this is a significant surgery with substantial impact on a woman’s body, it may offer the best chance for long-term control of the disease in certain situations.
For recurrent cancer that has spread to the pelvic area, doctors sometimes recommend pelvic exenteration, which is a major surgical procedure. This operation includes vulvectomy and removal of lymph nodes in the groin, plus removal of one or more pelvic organs such as the vagina, uterus, bladder, or rectum[3][14]. This extensive surgery is usually considered only when cancer has recurred locally in the pelvis and hasn’t spread to distant parts of the body. The procedure requires significant recovery time and results in permanent changes to bodily functions, but it can be life-saving for selected patients.
Radiation Therapy
Radiation therapy uses high-energy rays or particles to destroy cancer cells. For recurrent vulvar cancer, external radiation therapy may be delivered from a machine outside the body, directing beams of radiation to the affected area. This treatment can be used alone or combined with chemotherapy. Doctors may use radiation to shrink a tumor before surgery, making it easier to remove completely. This approach is called neoadjuvant therapy[3].
In some cases, radiation serves as palliative treatment, meaning it’s used to relieve pain or control symptoms rather than to cure the cancer. This can significantly improve quality of life for women with advanced recurrent disease. Brachytherapy, a type of internal radiation therapy, places radioactive material directly into or very near the tumor. This allows delivery of a high dose of radiation directly to cancer cells while minimizing exposure to surrounding healthy tissues[3].
Whether radiation therapy can be used depends partly on previous treatments. Women who received radiation during their initial treatment may have limitations on how much additional radiation can be safely delivered to the same area, as tissues can only tolerate a certain cumulative dose of radiation over a lifetime.
Chemotherapy
Chemotherapy uses powerful drugs to destroy cancer cells throughout the body. For recurrent vulvar cancer, chemotherapy is often combined with radiation therapy in an approach called chemoradiation. The chemotherapy drugs help make the cancer cells more sensitive to radiation, potentially improving treatment effectiveness. Common chemotherapy drugs used include cisplatin and paclitaxel, or carboplatin and paclitaxel[3][8].
Chemotherapy may also be offered when surgery isn’t possible due to health problems or the location and extent of the cancer. In cases of advanced recurrent cancer, chemotherapy can be used as palliative treatment to help control symptoms and potentially extend life, even when cure isn’t possible. The drugs travel through the bloodstream, reaching cancer cells that may have spread beyond the original site.
Targeted Therapy
Targeted therapy represents a newer approach that uses drugs designed to attack specific molecules on or inside cancer cells. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapy aims more precisely at cancer cells, potentially causing fewer side effects on normal tissues. For recurrent vulvar cancer, targeted therapy drugs like bevacizumab and erlotinib may be offered[3][8].
Bevacizumab works by blocking the formation of new blood vessels that tumors need to grow, essentially starving the cancer of nutrients and oxygen. Erlotinib targets specific proteins that help cancer cells grow and divide. These targeted therapy drugs are sometimes combined with chemotherapy drugs to enhance treatment effectiveness. However, these medications may not be covered by all health insurance plans, and patients should discuss coverage and costs with their healthcare team.
Living with Recurrent Vulvar Cancer
Receiving a diagnosis of recurrent vulvar cancer can be emotionally devastating. Many women experience a range of powerful emotions including shock, fear, anger, sadness, and uncertainty. These feelings are completely normal and valid. The intimate nature of vulvar cancer can make it particularly difficult to discuss, potentially leading to feelings of isolation or embarrassment. However, talking about these feelings and the diagnosis with trusted friends, family members, or healthcare providers can provide crucial support.
Physical changes resulting from treatment can significantly impact self-esteem and relationships. Surgical procedures, particularly extensive ones like vulvectomy or pelvic exenteration, cause permanent changes to the body that affect appearance, sexual function, and sometimes basic bodily functions. These changes require adjustment and may benefit from counseling or support groups where women can connect with others who have faced similar challenges.
Pain management becomes an important consideration during and after treatment. Depending on the treatment approach, the vulvar area may remain uncomfortable or sore for an extended period. Healthcare providers can offer various strategies for managing pain, from medications to other supportive measures that improve comfort and quality of life.
Practical matters also require attention. Keeping organized with a calendar for appointments, making lists of questions before doctor visits, and bringing a trusted person to appointments can help manage the complexity of ongoing care. Setting small, achievable goals and planning enjoyable activities can provide positive focus during difficult weeks of treatment.


